Related Experiment Video
Updated: Mar 8, 2026

Detection of Invasive Pulmonary Aspergillosis in Haematological Malignancy Patients by using Lateral-flow Technology
Published on: March 22, 2012
[A rare and mortal infection agent in patients with hematological malignancies: Saprochaete capitata]
Lale Aydın Kaynar, Zübeyde Nur Özkurt1, Burcu Ülküden
1Gazi University Faculty of Medicine, Department of Hematology, Ankara, Turkey. zubeydenurozkurt@yahoo.com.
Abstract:
Saprochaete capitata (formerly known as Geotrichum capitatum and Blastoschizomyces capitatus) is a rare invasive fungal agent that may lead to mortal clinical course in patients with hematological malignancies. This agent can be colonized in skin, lungs and intestines, and it can cause major opportunistic infections. Invasive systemic infections due to S.capitata have been reported in immunosuppressed patients. In this report, two patients with invasive S.capitata infections detected during the course of persistent neutropenic fever in acute leukemia, were presented. In both cases empirical caspofungin was added to the treatment, as no response was obtained by board-spectrum antibacterial therapy in neutropenic fever. In the first patient, there were no significant findings except the chronic inflammation observed in the biopsies which was performed for the symptoms of lymphadenitis, myositis, and hepatosplenic candidiasis. While persistent fever was on going, S.capitata was isolated from the blood and catheter cultures. There was no response after catheter removing and the introduction of amphotericin B and voriconazole therapy, therefore allogeneic stem cell transplantation plan for the second time for bone marrow aplasia was taken an earlier time. However, the patient died due to progressive pericardial and pleural effusion and multiorgan failure, although an afebrile process after stem cell transplantation could be obtained. Similarly the second patient had persistent fever despite empirical caspofungin treatment. The additional symptoms of diarrhea, abdominal pain and subileus have indicated an intraabdominal infection. During the follow up, S.capitata was isolated from the blood and catheter cultures. Catheter was removed and amphotericin B was initiated. No response was obtained, and voriconazole was added to treatment. Despite of an afebrile and culture-negative period, the patient died as a result of Acinetobacter sepsis and multiorgan failure. Minimal inhibitory concentration values for both of the Saprochete strains were found as 0.25 µg/ml for amfoterisin B, 1 µg/ml for flukonazol, 0.125 µg/ml for vorikonazol and 0.25 µg/ml for itrakonazol. Virulence model was created by injecting the isolates to the Galleria mellonella larvae, and the life cycle of the larvae were determined. The observation revealed that the infected larvae began to die on the second day and there was no live larvae remained on the eleventh day. In conclusion, S.capitata should be considered as an infection agent with high mortality risk in the neutropenic patients with hematologic malignancies, especially in the presence of persistent fever during the use of caspofungin.
Insights
Saprochaete capitata is a rare fungal pathogen causing invasive infections in patients with hematologic malignancies. Early identification and aggressive treatment are crucial, as this infection carries a high mortality risk, especially in neutropenic patients.
Area of Science:
- Mycology
- Infectious Diseases
- Hematology
Background:
- Saprochaete capitata (formerly Geotrichum capitatum) is a rare fungal agent causing invasive infections.
- It can colonize skin, lungs, and intestines, leading to opportunistic infections, particularly in immunosuppressed individuals.
- Invasive S. capitata infections have been reported in patients with hematological malignancies, often with a fatal outcome.
Observation:
- Two cases of invasive S. capitata infection in acute leukemia patients with persistent neutropenic fever are presented.
- Both patients received empirical caspofungin without response to broad-spectrum antibacterial therapy.
- S. capitata was isolated from blood and catheter cultures in both cases.
Findings:
- Despite antifungal treatment (amphotericin B, voriconazole) and interventions like stem cell transplantation, both patients experienced fatal outcomes.
- Minimal inhibitory concentrations (MICs) indicated susceptibility to amphotericin B, voriconazole, and itraconazole, but resistance to fluconazole.
- Virulence was confirmed in Galleria mellonella larvae model, showing rapid mortality post-infection.
Implications:
- S. capitata poses a high mortality risk in neutropenic patients with hematological malignancies.
- Persistent fever during caspofungin treatment in this patient population warrants consideration of S. capitata.
- Aggressive and timely management strategies are essential for improving outcomes in invasive S. capitata infections.
Related Concept Videos
Regulation of Hematopoietic Stem Cells
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Hematopoiesis
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...

